RxPONDER: Even More Women May Forgo Chemo for Breast Cancer ...Middle East

Medscape - News
The first results from RxPONDER provide insight – and controversy – regarding the need for chemotherapy by women with node-positive, low-risk HR+, HER2- breast cancer. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( RxPONDER: Even More Women May Forgo Chemo for Breast Cancer )

Apple Storegoogle play

Also on site :